AutoImmune-AIMM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AutoImmune-AIMM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: organ who wrote (48)	3/17/1997 7:22:00 PM
From: Thomas Stewart	of 298

Regis: I will call AIMM tomorrow to see if they can help with pricing and I can take a stab at market size. That may be a start at determining potential revenues anyway. Will pass such info along if I learn any. And Organ, as it has come to my attention that your remarks have alarmed one of the participants on this thread, and this rumor issue arises in many contexts, I will beat the dead horse once more. To draw a lesson from the courtroom: Hearsay is when one person describes what another has said. What you give us, by my count is double hearsay, and, what's worse, the declarant's ethics are thrown into question by the very act of disclosing the info. For anyone to move money on such a post is just nuts. I will now drop the issue. Sorry if I have belabored the point. You may be able to help out. Do you know or can you easily find out what percentage of MS patients are DR2+ and -? Thanks. And you are right to suggest that this stock may fall hard. Every investor here better be able to withstand the loss of his or her investment or better have hedged his or her position. PS. Gamma interferon exacerbates MS.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next